Vertex社ã®éãªããªã¤ãçµå£è¬suzetrigineãPh2試é¨ã§ãã©ã»ãã¨å·®ãã¤ãã ã» ã¿ã¤ãã«ãè¨æ£ãã¾ããã AIåµè¬insitro社ã5000ä¸ãã«æåBMS社ãæ±ããALS/èªç¥çæ²»çæ¢ãã«åãçµã ã» ã¿ã¤ãã«ãè¨æ£ãã¾ããï¼ç´åçâALS/èªç¥çï¼ Sanofi/Tevaã®æTL1Aæä½duvakitugã®æ½°çæ§å¤§è ¸ç/ã¯ãã¼ã³ç Ph2b試é¨æå 㻠誤è¨ãè¨æ£ãã¾ããï¼é«ç¨éã¨ä½ç¨éâä½ç¨éã¨é«ç¨éï¼ 2008-10-09 - 29試é¨ã®ã¬ãã¥ã¼ã®çµæããã¼ãã»ã»ã³ãã¸ã§ã³ãºã¯ã¼ãï¼St. John's wortï¼ã®æãã¤ä½ç¨ã¯ãã©ã»ããããåªãã¦ãããæ¨æºçãªæãã¤è¬ã¨åçã¨ç¤ºåããã¾ãããã¾ããæ¨æºçãªæãã¤è¬ãããã»ã³ãã¸ã§ã³ãºã¯ã¼ãã®æ¹ãå¯ä½ç¨ãå°ãªãã¨èãããã¾ããã (3 段è½, 258 æå) [å ¨æãèªãã«ã¯ææä¼å¡ç»é²ãå¿ è¦ã§ã] [ææä¼å¡ç»é²ãã
{{#tags}}- {{label}}
{{/tags}}